Vertex Pharmaceuticals to Participate in September Investor Conferences
ByAinvest
Wednesday, Aug 20, 2025 4:02 pm ET1min read
VRTX--
Wells Fargo Healthcare Conference
Susie Lisa, Senior Vice President, Investor Relations, and Manisha Pai, Executive Director, Investor Relations, will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 11:00 a.m. ET. This event is an opportunity for investors to gain insights into the company's strategic direction and financial performance.
Morgan Stanley 23rd Annual Global Healthcare Conference
Reshma Kewalramani, President and Chief Executive Officer, and Duncan McKechnie, Executive Vice President and Chief Commercial Officer, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025, at 11:30 a.m. ET. This conference is a platform for Vertex to discuss its innovations and growth prospects.
Bank of America Global Healthcare Conference London
Susie Lisa will also participate in a fireside chat at the Bank of America Global Healthcare Conference London on Tuesday, September 23, at 8:10 a.m. GMT. This event offers investors a chance to hear from Vertex's leadership about its global operations and future plans.
Vertex Pharmaceuticals is a global biotechnology company with a strong track record in developing transformative medicines for serious diseases. The company has approved therapies for cystic fibrosis, sickle cell disease, and transfusion-dependent beta thalassemia, among others. It continues to advance clinical and research programs in these areas and has a robust pipeline of investigational therapies across various modalities.
The company's leadership participation in these conferences underscores its commitment to transparency and investor engagement. For more information and to access the live webcasts, investors can visit the Vertex website.
References
[1] https://www.businesswire.com/news/home/20250820369043/en/Vertex-to-Participate-in-Upcoming-September-Investor-Conferences
[2] https://www.ainvest.com/news/top-3-growth-stocks-buy-august-eli-lilly-summit-therapeutics-vertex-pharmaceuticals-2508/
Vertex Pharmaceuticals will participate in three investor conferences in September: the 2025 Wells Fargo Healthcare Conference, Morgan Stanley's 23rd Annual Global Healthcare Conference, and the Bank of America Global Healthcare Conference London. The conferences will feature management participation in fireside chats, and live webcasts of the events will be available on the company's website. Vertex is a global biotechnology company with approved therapies for cystic fibrosis, sickle cell disease, and other serious diseases.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will participate in three significant investor conferences in September, providing investors with opportunities to engage with the company's leadership. The engagements include fireside chats and live webcasts, accessible through the company's website.Wells Fargo Healthcare Conference
Susie Lisa, Senior Vice President, Investor Relations, and Manisha Pai, Executive Director, Investor Relations, will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, at 11:00 a.m. ET. This event is an opportunity for investors to gain insights into the company's strategic direction and financial performance.
Morgan Stanley 23rd Annual Global Healthcare Conference
Reshma Kewalramani, President and Chief Executive Officer, and Duncan McKechnie, Executive Vice President and Chief Commercial Officer, will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025, at 11:30 a.m. ET. This conference is a platform for Vertex to discuss its innovations and growth prospects.
Bank of America Global Healthcare Conference London
Susie Lisa will also participate in a fireside chat at the Bank of America Global Healthcare Conference London on Tuesday, September 23, at 8:10 a.m. GMT. This event offers investors a chance to hear from Vertex's leadership about its global operations and future plans.
Vertex Pharmaceuticals is a global biotechnology company with a strong track record in developing transformative medicines for serious diseases. The company has approved therapies for cystic fibrosis, sickle cell disease, and transfusion-dependent beta thalassemia, among others. It continues to advance clinical and research programs in these areas and has a robust pipeline of investigational therapies across various modalities.
The company's leadership participation in these conferences underscores its commitment to transparency and investor engagement. For more information and to access the live webcasts, investors can visit the Vertex website.
References
[1] https://www.businesswire.com/news/home/20250820369043/en/Vertex-to-Participate-in-Upcoming-September-Investor-Conferences
[2] https://www.ainvest.com/news/top-3-growth-stocks-buy-august-eli-lilly-summit-therapeutics-vertex-pharmaceuticals-2508/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet